CSF soluble proteins and vigabatrin.
Persson
L
L
D000614:Aminocaproates / Q000009:adverse effects*; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D001921:Brain / Q000473:pathology; D001923:Brain Chemistry / Q000187:drug effects; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis*; D004827:Epilepsy / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D009410:Nerve Degeneration / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D002556:Cerebrospinal Fluid Proteins; D020888:Vigabatrin